ISPH fundamentals
An in-depth look to IBNSINA PHARMA operating, investing, and financing activities
ISPH free cash flow for Q4 23 is 492.69 M EGP. For 2023, ISPH free cash flow was -228.23 M EGP and operating cash flow was 125.81 M EGP.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM